Age-related macular degeneration is the leading cause of vision loss in those who are age 50 or older. In fact, almost 20 million people in the U.S. have some type of age-related macular ...

The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

Microlenses applied to eyeglasses can help reduce growth-related worsening of nearsightedness (myopia), preventing potential ...

Long-term stabilizing of retinal exudation and fluid accumulation contributes to brolucizumab’s efficacy in managing wet age-related macular degeneration (AMD). Visual prognosis could be improved when ...

"The laser beam can be positioned with great accuracy on surfaces, so we can produce significantly smaller microlenses than is possible with previously existing methods," commented Thomas Höche head ...

The aim of this article is to give an overview of several modalities of treatment of CNV in myopes, including laser photocoagulation ... patients with myopic macular degeneration complicated ...

If you look up at the sky on a clear day, you might notice little cobweb-like structures drifting across your field of vision ...

Healthcare has always been at the forefront of human innovation, but recent advancements in precision tools and modern ...

New research found that high levels of ‘good cholesterol’ in the blood were associated with an increased risk of glaucoma, an ...

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...

Red light therapy is increasingly viewed as a promising treatment for wrinkles, acne, psoriasis, scars and sun-damaged skin, and as a supportive therapy for some kinds of cancer. But does red light ...